Home > Treatment Options > Tumor Suppressors >

Endostatin (Endostar™)


Bortezomib, Cemical Structure

Index

  1. Basic Information
  2. Concerns
  3. Other Conditions
  4. Side Effects
  5. Sources
  • Trial Availability: USA
  • Tumor Target: Vestibular Schwannoma
  • Active, Not Recruiting: NCT02104323

Sources

  1. Li, Kai, Mingliang Shi, and Shukui Qin. "Current Status and Study Progress of Recombinant Human Endostatin in Cancer Treatment." Oncology and Therapy (2018): 1-23. https://link.springer.com/article/10.1007/s40487-017-0055-1